Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Scher

Showing results (251-260 of 825) with videos related to

Pageof 83
Sort By:
Seminars in Oncology|October 1, 1990
Can we combine available data to evaluate the effects of neoadjuvant chemotherapy for invasive bladder cancer?N L Geller, H I Scher, M K Parmar, et al.
Investigational New Drugs|February 1, 1993
Phase II trial of gallium nitrate in previously treated patients with small cell lung cancerJ Baselga, M G Kris, H I Scher, et al.
Current Oncology Reports|April 7, 2004
Targeting osseous metastases: rationale and development of radio-immunotherapy for prostate cancerMichael J Morris, Neeta Pandit-Taskar, Chaitanya Divgi, et al.
Endocrine-Related Cancer|September 17, 2004
Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancerHoward I Scher, Grant Buchanan, William Gerald, et al.
The Journal of Experimental Medicine|December 1, 1973
Specific murine B-cell activation by synthetic single-and double-stranded polynucleotidesI Scher, D M Strong, A Ahmed, et al.
Current Urology Reports|May 5, 2005
Targeting osseous metastases: rationale and development of radio-immunotherapy for prostate cancerMichael J Morris, Neeta Pandit-Taskar, Chaitanya Divgi, et al.
Cancer Investigation|January 1, 1985
Experimental studies and phase II trial of bisantrene in advanced urothelial malignanciesH I Scher, T Ahmed, A Yagoda, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1980
Heterogeneity of Ia expression on normal B cells, neonatal B cells, and on cells from B cell-defective CBA/N miceJ J Mond, S Kessler, F D Finkelman, et al.
European Journal of Immunology|July 1, 1978
T-independent responses in B cell-defective CBA/N mice to Brucella abortus and to trinitrophenyl (TNP) conjugates of Brucella abortusJ J Mond, I Scher, D E Mosier, et al.
Progress in Clinical and Biological Research|January 1, 1989
Neoadjuvant chemotherapy of invasive bladder cancer. The prognostic value of local tumor responseT A Splinter, L Denis, H I Scher, et al.
Pageof 83

Showing results (251-260 of 825) with videos related to

Sort By:
Pageof 83
Seminars in Oncology|October 1, 1990
Can we combine available data to evaluate the effects of neoadjuvant chemotherapy for invasive bladder cancer?N L Geller, H I Scher, M K Parmar, et al.
Investigational New Drugs|February 1, 1993
Phase II trial of gallium nitrate in previously treated patients with small cell lung cancerJ Baselga, M G Kris, H I Scher, et al.
Current Oncology Reports|April 7, 2004
Targeting osseous metastases: rationale and development of radio-immunotherapy for prostate cancerMichael J Morris, Neeta Pandit-Taskar, Chaitanya Divgi, et al.
Endocrine-Related Cancer|September 17, 2004
Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancerHoward I Scher, Grant Buchanan, William Gerald, et al.
The Journal of Experimental Medicine|December 1, 1973
Specific murine B-cell activation by synthetic single-and double-stranded polynucleotidesI Scher, D M Strong, A Ahmed, et al.
Current Urology Reports|May 5, 2005
Targeting osseous metastases: rationale and development of radio-immunotherapy for prostate cancerMichael J Morris, Neeta Pandit-Taskar, Chaitanya Divgi, et al.
Cancer Investigation|January 1, 1985
Experimental studies and phase II trial of bisantrene in advanced urothelial malignanciesH I Scher, T Ahmed, A Yagoda, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1980
Heterogeneity of Ia expression on normal B cells, neonatal B cells, and on cells from B cell-defective CBA/N miceJ J Mond, S Kessler, F D Finkelman, et al.
European Journal of Immunology|July 1, 1978
T-independent responses in B cell-defective CBA/N mice to Brucella abortus and to trinitrophenyl (TNP) conjugates of Brucella abortusJ J Mond, I Scher, D E Mosier, et al.
Progress in Clinical and Biological Research|January 1, 1989
Neoadjuvant chemotherapy of invasive bladder cancer. The prognostic value of local tumor responseT A Splinter, L Denis, H I Scher, et al.
Pageof 83